Pluvicto

(vipivotide tetraxetan)
12.5 ML lutetium Lu 177 vipivotide tetraxetan 27 MCI/ML Injection [Pluvicto]
NO BLACK BOX WARNING

Dosage & administration

biomarker testing

Pluvicto clinical details

Genetic testing requirements were obtained from the NCCN guidelines for each cancer type.

drug label

Pluvicto prescribing information

prior authorization

Pluvicto prior authorization resources

PDF
Coverage Authorization Appeals
Learn More

Benefits investigation

PDF
AAA PatientCONNECT Pluvicto Enrollment Form
Learn More

financial assistance

Pluvicto financial assistance options

Co-pay savings program

commercial only

PDF
AAA PatientCONNECT Pluvicto Enrollment Form

OTHER
Enroll in Patient Savings Program
Learn More

Foundation programs

under insured
no insurance
goverment insurance
65+

PDF
AAA PatientCONNECT Pluvicto Enrollment Form
Learn More

patient education

Pluvicto patient education

Getting started on Pluvicto

To share resource; ask patient to:
1.Pull out phone
2.Open camera
3.Scan QR code with camera
4.Tap link

Patient toolkit

PDF
Patient Brochure
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

PDF
AAA PatientCONNECT Patient Brochure
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

BRAND PAGE
About Pluvicto
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

OTHER
Receiving Pluvicto
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

BRAND PAGE
Side Effects
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

VIDEO
Patient Stories
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Learn More

Other resources

Learn More

people also ask

Pluvicto FAQs

How is the dosage of Pluvicto?Pluvicto is available in 1 dosages, including 177-27 var units Injection 12.5 ml
What does Pluvicto treat?Pluvicto treats Prostatic Neoplasms
How Is Pluvicto Administered?Pluvicto is administered as a Injectable
FAQ Data Source